Zacks Investment Research
07 Aug 2026, 00:31 UTC · 14w ago
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
Impact · against what's priced in
ICU Medical (ICUI) showed strong bottom-line performance with a 24.08% EPS beat, though top-line growth remains stagnant at 0.8% year-over-year. The earnings surprise suggests improved operational efficiency despite the flat revenue trajectory.
- ICUI+0.40
No priced-in read yet
- In context
The company reported a significant EPS beat of $2.37 against a $1.91 estimate, though revenue growth is nearly flat at 0.8% year-over-year.
Read from the article alone

Search tags




